BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

674 related articles for article (PubMed ID: 24357736)

  • 1. Lung cancer screening: advantages, controversies, and applications.
    Nanavaty P; Alvarez MS; Alberts WM
    Cancer Control; 2014 Jan; 21(1):9-14. PubMed ID: 24357736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of CT screening in the National Lung Screening Trial.
    Black WC; Gareen IF; Soneji SS; Sicks JD; Keeler EB; Aberle DR; Naeim A; Church TR; Silvestri GA; Gorelick J; Gatsonis C;
    N Engl J Med; 2014 Nov; 371(19):1793-802. PubMed ID: 25372087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung cancer screening: the radiologist's perspective.
    Prokop M
    Semin Respir Crit Care Med; 2014 Feb; 35(1):91-8. PubMed ID: 24481763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computed tomography screening for lung cancer in the National Lung Screening Trial: a cost-effectiveness analysis.
    Black WC
    J Thorac Imaging; 2015 Mar; 30(2):79-87. PubMed ID: 25635704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for lung cancer. Too many uncertainties, even for smokers.
    Prescrire Int; 2014 Jan; 23(145):19-23. PubMed ID: 24516909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current estimate of costs of lung cancer screening in the United States.
    Mauchley DC; Mitchell JD
    Thorac Surg Clin; 2015 May; 25(2):205-15. PubMed ID: 25901564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rationale for, and design of, a lung cancer screening program.
    Mazzone P
    Cleve Clin J Med; 2012 May; 79(5):337-45. PubMed ID: 22550076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating Lung Cancer Screening Uptake, Outcomes, and Costs in the United States: Challenges With Existing Data and Recommendations for Improvement.
    Rai A; Doria-Rose VP; Silvestri GA; Yabroff KR
    J Natl Cancer Inst; 2019 Apr; 111(4):342-349. PubMed ID: 30698792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the Optimum Screening Strategy for the Early Detection of Lung Cancer.
    Baldwin DR; Callister ME
    Clin Oncol (R Coll Radiol); 2016 Nov; 28(11):672-681. PubMed ID: 27544425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Economic impact of lung cancer screening in France: A modeling study].
    Gendarme S; Perrot É; Reskot F; Bhoowabul V; Fourre G; Souquet PJ; Milleron B; Couraud S
    Rev Mal Respir; 2017 Sep; 34(7):717-728. PubMed ID: 26585377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding Cost-Effectiveness Analyses: An Explanation Using Three Different Analyses of Lung Cancer Screening.
    Curl PK; Kahn JG; Ordovas KG; Elicker BM; Naeger DM
    AJR Am J Roentgenol; 2015 Aug; 205(2):344-7. PubMed ID: 26204285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computed tomography screening for lung cancer.
    Boiselle PM
    JAMA; 2013 Mar; 309(11):1163-70. PubMed ID: 23512063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trade-off between benefits, harms and economic efficiency of low-dose CT lung cancer screening: a microsimulation analysis of nodule management strategies in a population-based setting.
    Treskova M; Aumann I; Golpon H; Vogel-Claussen J; Welte T; Kuhlmann A
    BMC Med; 2017 Aug; 15(1):162. PubMed ID: 28838313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating the Cost-Effectiveness of Lung Cancer Screening with Low-Dose Computed Tomography for High-Risk Smokers in Australia.
    Wade S; Weber M; Caruana M; Kang YJ; Marshall H; Manser R; Vinod S; Rankin N; Fong K; Canfell K
    J Thorac Oncol; 2018 Aug; 13(8):1094-1105. PubMed ID: 29689434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung cancer screening: did we really need a randomized controlled trial?
    Al-Ayoubi AM; Flores RM
    Eur J Cardiothorac Surg; 2016 Jul; 50(1):29-33. PubMed ID: 27005972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung cancer screening and management.
    Jones GS; Baldwin DR
    Minerva Med; 2015 Dec; 106(6):339-54. PubMed ID: 26605556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evidence for low-dose CT screening of lung cancer.
    Ruchalski K; Gutierrez A; Genshaft S; Abtin F; Suh R
    Clin Imaging; 2016; 40(2):288-95. PubMed ID: 26362352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Screening for lung cancer using CT: time for implementation?].
    de Jong PA; Lammers JW
    Ned Tijdschr Geneeskd; 2013; 157(46):A7019. PubMed ID: 24220184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical Care Costs Were Similar Across the Low-dose Computed Tomography and Chest X-Ray Arms of the National Lung Screening Trial Despite Different Rates of Significant Incidental Findings.
    Gareen IF; Black WC; Tosteson TD; Wang Q; Sicks JD; Tosteson ANA
    Med Care; 2018 May; 56(5):403-409. PubMed ID: 29613874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lung cancer screening with low dose CT requires careful consideration].
    Saghir Z; Dirksen A; Ashraf H; Bach KS; Brodersen J; Clementsen PF; Døssing M; Hansen H; Kofoed KF; Larsen KR; Mortensen J; Rasmussen JF; Thomsen LH; Wille MM; Seersholm N; Skov BG; Thorsen H; Tønnesen P; Pedersen JH
    Ugeskr Laeger; 2014 Oct; 176(42):. PubMed ID: 25316363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.